NO994823L - Benzocykloheptatiofenforbindelser - Google Patents

Benzocykloheptatiofenforbindelser

Info

Publication number
NO994823L
NO994823L NO994823A NO994823A NO994823L NO 994823 L NO994823 L NO 994823L NO 994823 A NO994823 A NO 994823A NO 994823 A NO994823 A NO 994823A NO 994823 L NO994823 L NO 994823L
Authority
NO
Norway
Prior art keywords
analogs
compounds
substituted
cycloheptal
carboxyalkyloxyalkyl
Prior art date
Application number
NO994823A
Other languages
English (en)
Other versions
NO994823D0 (no
NO311934B1 (no
Inventor
A K Gunnar Aberg
George E Wright
Jan L Chen
Original Assignee
Bridge Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bridge Pharma Inc filed Critical Bridge Pharma Inc
Publication of NO994823D0 publication Critical patent/NO994823D0/no
Publication of NO994823L publication Critical patent/NO994823L/no
Publication of NO311934B1 publication Critical patent/NO311934B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Curing Cements, Concrete, And Artificial Stone (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO19994823A 1997-04-03 1999-10-04 Benzocykloheptatiofenforbindelser NO311934B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US4390597P 1997-04-03 1997-04-03
PCT/US1998/006576 WO1998043640A1 (en) 1997-04-03 1998-04-02 Benzocycloheptathiophene compounds

Publications (3)

Publication Number Publication Date
NO994823D0 NO994823D0 (no) 1999-10-04
NO994823L true NO994823L (no) 1999-10-07
NO311934B1 NO311934B1 (no) 2002-02-18

Family

ID=21929513

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994823A NO311934B1 (no) 1997-04-03 1999-10-04 Benzocykloheptatiofenforbindelser

Country Status (17)

Country Link
US (1) US6207683B1 (no)
EP (1) EP0977568B1 (no)
JP (1) JP2001519789A (no)
KR (1) KR20010005791A (no)
CN (1) CN1128789C (no)
AT (1) ATE319450T1 (no)
AU (1) AU733325B2 (no)
BR (1) BR9807911A (no)
CA (1) CA2283663C (no)
DE (1) DE69833748T2 (no)
ID (1) ID24487A (no)
IL (1) IL131999A (no)
NO (1) NO311934B1 (no)
NZ (1) NZ337843A (no)
PL (1) PL336007A1 (no)
RU (1) RU2193557C2 (no)
WO (1) WO1998043640A1 (no)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908014D0 (en) * 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
RU2266115C2 (ru) * 1999-09-13 2005-12-20 Бридж Фарма, Инк. Оптически активные изомеры кетотифена и их терапевтически активные метаболиты
PL353586A1 (en) 1999-09-13 2003-12-01 Bridge Pharma, Inc.Bridge Pharma, Inc. Optically active isomers of ketotifen and therapeutically active metabolites thereof
RU2235536C1 (ru) * 2003-02-10 2004-09-10 Государственное образовательное учреждение высшего профессионального образования башкирский государственный медицинский университет Средство для лечения заболевания глаз с метронидазолом
RU2242977C1 (ru) * 2003-09-30 2004-12-27 Плотников Евгений Владимирович Антивирусная и бактерицидная композиция
WO2008153761A1 (en) * 2007-05-23 2008-12-18 Mastcell Pharmaceuticals, Inc. Methods
TWI429641B (zh) * 2008-01-30 2014-03-11 Nippon Zoki Pharmaceutical Co 哌啶衍生物
WO2009142772A2 (en) * 2008-05-23 2009-11-26 Mastcell Pharmaceuticals, Inc. Methods and treatment for allergies and inflammation associated with gastrointestinal diseases
JP5083989B2 (ja) * 2008-11-20 2012-11-28 日本臓器製薬株式会社 ピペリジン誘導体を含有する医薬
JP2012520880A (ja) * 2009-03-17 2012-09-10 アーシエックス セラピューティックス, インコーポレイテッド ケトチフェンの眼科用製剤および使用方法
US9296731B2 (en) 2011-06-28 2016-03-29 Fujian Mindong Rejuvenation Pharmaceutical Co., Ltd. Anti-allergy benzocycloheptathiophene derivatives
US8778971B2 (en) 2012-10-23 2014-07-15 Bridge Pharma, Inc. Medicinal treatment of dermal diseases in companion animals
US8557846B1 (en) 2012-10-23 2013-10-15 Bridge Pharma, Inc. Medicinal treatment of dermal diseases in dogs
US20150272941A1 (en) 2012-10-30 2015-10-01 Bridge Pharma, Inc. Medicinal treatment of chronic pulmonary inflammatory diseases with norketotifen
US20140120121A1 (en) 2012-10-30 2014-05-01 Bridge Pharma, Inc. Medicinal treatment of atopic inflammatory diseases
US9345697B2 (en) 2013-08-06 2016-05-24 Bridge Pharma, Inc. Methods of treatment of non-histaminic pruritus
US9138431B2 (en) 2013-08-06 2015-09-22 Bridge Pharma, Inc. Methods of treatment of histamine H-4 receptor-related pruritus
US9439895B2 (en) 2013-08-06 2016-09-13 Bridge Pharma, Inc. Methods of treating pruritic conditions mediated through non-histaminergic mechanisms in diabetic patients
CN104045633B (zh) * 2014-06-26 2017-07-21 福建省闽东力捷迅药业有限公司 一种富马酸卢帕替芬晶型a及其制备方法
CN104031035B (zh) * 2014-06-26 2017-08-25 福建省闽东力捷迅药业有限公司 一种富马酸卢帕替芬混晶及其制备方法
EP3307270B1 (en) * 2015-06-11 2018-10-17 Bridge Pharma, Inc. Methods of treatment of non-histaminic pruritus in mammals
MY204310A (en) 2016-09-08 2024-08-22 Emergo Therapeutics Inc Mast cell stabilizers for treatment of hypercytokinemia and viral infection
US11478463B2 (en) 2016-10-18 2022-10-25 Emergo Therapeutics, Inc. Mast cell stabilizers for treatment of chronic inflammatory conditions
CN109180666A (zh) * 2018-09-07 2019-01-11 福建省闽东力捷迅药业有限公司 一种富马酸卢帕替芬的杂质c及其制备方法和检测方法
CN115960135B (zh) * 2022-07-21 2025-03-25 华创合成制药股份有限公司 抗组胺类化合物及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1470263A1 (de) * 1963-12-19 1969-05-29 Sandoz Ag Neue Heterocyclische Verbindungen und Verfahren zu ihrer Herstellung
DE2626583A1 (de) * 1975-06-24 1977-01-13 Sandoz Ag Neue benzocycloheptathiophenderivate ihre herstellung und ihre verwendung als heilmittel
US4255036A (en) * 1979-05-25 1981-03-10 Pincetich Vincent J Handheld support for camera and photographic lamp
US4355036A (en) 1980-06-19 1982-10-19 Schering Corporation Tricyclic-substituted piperidine antihistamines
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
GB2309948A (en) * 1996-02-10 1997-08-13 Michael Anthony Mumford Limiting vehicle roll

Also Published As

Publication number Publication date
NZ337843A (en) 2001-11-30
US6207683B1 (en) 2001-03-27
CA2283663A1 (en) 1998-10-08
HK1027961A1 (en) 2001-02-02
KR20010005791A (ko) 2001-01-15
ID24487A (id) 2000-07-20
EP0977568B1 (en) 2006-03-08
CA2283663C (en) 2006-07-25
AU733325B2 (en) 2001-05-10
WO1998043640A1 (en) 1998-10-08
CN1128789C (zh) 2003-11-26
EP0977568A4 (en) 2001-03-21
BR9807911A (pt) 2000-02-22
NO994823D0 (no) 1999-10-04
EP0977568A1 (en) 2000-02-09
ATE319450T1 (de) 2006-03-15
AU6881298A (en) 1998-10-22
JP2001519789A (ja) 2001-10-23
CN1258219A (zh) 2000-06-28
IL131999A (en) 2004-06-20
IL131999A0 (en) 2001-03-19
DE69833748D1 (de) 2006-05-04
PL336007A1 (en) 2000-06-05
RU2193557C2 (ru) 2002-11-27
DE69833748T2 (de) 2006-11-23
NO311934B1 (no) 2002-02-18

Similar Documents

Publication Publication Date Title
NO994823D0 (no) Benzocykloheptatiofenforbindelser
EE9900413A (et) Medikamentide kontrollitud väljutamine silma eeskambrisse
BG106586A (en) Pyrazolopyramidines as therapeutic agents
BG104561A (en) Aryl fused azapolycyclic compounds
SE9504661D0 (sv) New compounds
UA72881C2 (uk) Похідні тієнопіридину, фармацевтична композиція з використанням таких сполук (варіанти), проміжна сполука
ATE240344T1 (de) Nor-pregnane zur induzierung hypothalamischer effekte
MX9305248A (es) Compuestos de diarilpiperazinoacetamida.
EP0781561A4 (en) A NEW MEDICAL USE OF A 5HT 3? ANTAGONIST
DK0998287T3 (da) Anvendelse af levobupivacain
FI912621A7 (fi) Farmakologisesti aktiivisia keskushermostoon vaikuttavia yhdisteitä
IL143105A0 (en) Fused polycyclic heterocyclic compounds and pharmaceutical compositions containing the same
DE69430699D1 (de) Medikamente abgebende stents
DK0966277T3 (da) Anvendelse af R-NSAID'er til forebyggelse af Alzheimer's sygdom
FI912622A7 (fi) Farmakologisesti aktiivisia keskushermostoon vaikuttavia yhdisteitä
SE9504662D0 (sv) New compounds
CA2260863A1 (en) Treatment of psychotic disorders
MY118384A (en) Benzocycloheptathiophene compounds
PT1212119E (pt) Utilizacao de ciamemazina no tratamento do desmame subito de benzodiazepinas
FI914923L (fi) Foerfarande foer framstaellning av 5,11 -dihydro-6h-dipyrido-/3,2-b:2',3'-e//1,4/diazepiner. knippe.
IT1296613B1 (it) Farmaco per la cura dell'ircismo contenente un adrenocorticosteroide.
KR930010200U (ko) 무좀, 습진방지용 발가락 밴드
KR940018814U (ko) 신의 조립식 굽
ITMI930630A0 (it) Procedimento per la copolimerizzazione dell'etilene
IT1266787B1 (it) Composizioni terapeutiche ad attivita' antitumorale a base di derivati 1,3,8,10 tetrasostituiti del 4,5,6,7-tetratiocino-(1,2-b: 3,4-b')-